Anti-malaria MAb in Malian Children

Clinical trial NCT05304611 · COMPLETED

Trial details

NCT number: NCT05304611
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plasmodium Falciparum Infection Malaria

Start date: 2022-03-18
Primary completion: 2024-04-20
Enrollment: 365

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.